{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:12:43Z","timestamp":1789679563904,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10633-025-10016-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T17:47:06Z","timestamp":1743875226000},"page":"155-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotypic spectrum and theoretical prime editing analysis of WDR19-mediated retinal degeneration"],"prefix":"10.1007","volume":"150","author":[{"given":"Jorge","family":"Pincay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Lopes","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M. J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian D.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet R.","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9082-2427","authenticated-orcid":false,"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"4","key":"10016_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2009.10.036","volume":"139","author":"EA Nigg","year":"2009","unstructured":"Nigg EA, Raff JW (2009) Centrioles, centrosomes, and cilia in health and disease. Cell 139(4):663\u2013678","journal-title":"Cell"},{"issue":"5","key":"10016_CR2","doi-asserted-by":"publisher","first-page":"028175","DOI":"10.1101\/cshperspect.a028175","volume":"9","author":"F Bangs","year":"2017","unstructured":"Bangs F, Anderson KV (2017) Primary cilia and mammalian hedgehog signaling. Cold Spring Harb Perspect Biol 9(5):028175","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10016_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0070-2153(08)00605-4","volume":"84","author":"RJ Quinlan","year":"2008","unstructured":"Quinlan RJ, Tobin JL, Beales PL (2008) Modeling ciliopathies: primary cilia in development and disease. Curr Top Dev Biol 84:249\u2013310","journal-title":"Curr Top Dev Biol"},{"key":"10016_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/hmg\/ddg061","volume":"12","author":"I Iba\u00f1ez-Tallon","year":"2003","unstructured":"Iba\u00f1ez-Tallon I, Heintz N, Omran H (2003) To beat or not to beat: roles of cilia in development and disease. Hum Mol Genet 12:27\u201335","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10016_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMra1010172","volume":"364","author":"F Hildebrandt","year":"2011","unstructured":"Hildebrandt F, Benzing T, Katsanis N (2011) Ciliopathies. N Engl J Med 364(16):1533\u20131543","journal-title":"N Engl J Med"},{"issue":"1","key":"10016_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/humu.23362","volume":"39","author":"W Zhang","year":"2018","unstructured":"Zhang W et al (2018) Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies. Hum Mutat 39(1):152\u2013166","journal-title":"Hum Mutat"},{"issue":"8","key":"10016_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00467-014-2762-2","volume":"29","author":"H Fehrenbach","year":"2014","unstructured":"Fehrenbach H et al (2014) Mutations in WDR19 encoding the intraflagellar transport component IFT144 cause a broad spectrum of ciliopathies. Pediatr Nephrol 29(8):1451\u20131456","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10016_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ajmg.c.31336","volume":"160","author":"C Huber","year":"2012","unstructured":"Huber C, Cormier-Daire V (2012) Ciliary disorder of the skeleton. Am J Med Genet C Semin Med Genet 160(3):165\u2013174","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"10016_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ajhg.2011.10.001","volume":"89","author":"C Bredrup","year":"2011","unstructured":"Bredrup C et al (2011) Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19. Am J Hum Genet 89(5):634\u2013643","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10016_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/cge.12196","volume":"84","author":"RG Coussa","year":"2013","unstructured":"Coussa RG et al (2013) WDR19: an ancient, retrograde, intraflagellar ciliary protein is mutated in autosomal recessive retinitis pigmentosa and in Senior-Loken syndrome. Clin Genet 84(2):150\u2013159","journal-title":"Clin Genet"},{"issue":"3","key":"10016_CR11","doi-asserted-by":"publisher","first-page":"028191","DOI":"10.1101\/cshperspect.a028191","volume":"9","author":"DA Braun","year":"2017","unstructured":"Braun DA, Hildebrandt F (2017) Ciliopathies. Cold Spring Harb Perspect Biol 9(3):028191","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"10016_CR12","doi-asserted-by":"publisher","first-page":"28274","DOI":"10.1101\/cshperspect.a028274","volume":"9","author":"KM Bujakowska","year":"2017","unstructured":"Bujakowska KM, Liu Q, Eric A (2017) Pierce, Photoreceptor Cilia and Retinal Ciliopathies. Cold Spring Harb Perspect Biol 9(10):28274","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"17","key":"10016_CR13","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.2174\/0929867325666180105102447","volume":"26","author":"CR Uytingco","year":"2019","unstructured":"Uytingco CR, Green WW, Martens JR (2019) Olfactory loss and dysfunction in ciliopathies: molecular mechanisms and potential therapies. Curr Med Chem 26(17):3103\u20133119","journal-title":"Curr Med Chem"},{"key":"10016_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/978-1-4614-3209-8_67","volume":"801","author":"N Sorusch","year":"2014","unstructured":"Sorusch N et al (2014) Usher syndrome protein network functions in the retina and their relation to other retinal ciliopathies. Adv Exp Med Biol 801:527\u2013533","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10016_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ajo.2015.06.032","volume":"160","author":"T Sujirakul","year":"2015","unstructured":"Sujirakul T et al (2015) Multimodal imaging of central retinal disease progression in a 2-year mean follow-up of retinitis pigmentosa. Am J Ophthalmol 160(4):786\u201398.e4","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"10016_CR16","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1167\/iovs.11-8319","volume":"52","author":"F Delori","year":"2011","unstructured":"Delori F et al (2011) Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci 52(13):9379\u20139390","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10016_CR17","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1167\/iovs.13-12445","volume":"54","author":"JP Greenberg","year":"2013","unstructured":"Greenberg JP et al (2013) Quantitative fundus autofluorescence in healthy eyes. Invest Ophthalmol Vis Sci 54(8):5684\u20135693","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10016_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-017-9621-y","volume":"136","author":"AG Robson","year":"2018","unstructured":"Robson AG et al (2018) ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol 136(1):1\u201326","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10016_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/biomedicines11020385","volume":"11","author":"B Lopes da Costa","year":"2023","unstructured":"Lopes da Costa B et al (2023) Clinical and therapeutic evaluation of the ten most prevalent CRB1 mutations. Biomedicines 11(2):385","journal-title":"Biomedicines"},{"issue":"5","key":"10016_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"key":"10016_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100774","volume":"74","author":"JR Sparrow","year":"2020","unstructured":"Sparrow JR et al (2020) Lessons learned from quantitative fundus autofluorescence. Prog Retin Eye Res 74:100774","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10016_CR22","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1167\/iovs.13-13624","volume":"55","author":"TR Burke","year":"2014","unstructured":"Burke TR et al (2014) Quantitative fundus autofluorescence in recessive Stargardt disease. Invest Ophthalmol Vis Sci 55(5):2841\u20132852","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10016_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/genes14020291","volume":"14","author":"J Sajovic","year":"2023","unstructured":"Sajovic J et al (2023) Stargardt-like clinical characteristics and disease course associated with variants in the WDR19 gene. Genes (Basel) 14(2):291","journal-title":"Genes (Basel)"},{"issue":"4","key":"10016_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.preteyeres.2011.03.001","volume":"30","author":"A Mockel","year":"2011","unstructured":"Mockel A et al (2011) Retinal dystrophy in Bardet-Biedl syndrome and related syndromic ciliopathies. Prog Retin Eye Res 30(4):258\u2013274","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"10016_CR25","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1167\/iovs.16-19313","volume":"57","author":"CS Langlo","year":"2016","unstructured":"Langlo CS et al (2016) Residual foveal cone structure in CNGB3-associated achromatopsia. Invest Ophthalmol Vis Sci 57(10):3984\u20133995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10016_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/jamaophthalmol.2014.5963","volume":"133","author":"Z Wu","year":"2015","unstructured":"Wu Z et al (2015) Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. JAMA Ophthalmol 133(4):442\u2013448","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10016_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cne.902950113","volume":"295","author":"DS Williams","year":"1990","unstructured":"Williams DS, Arikawa K, Paallysaho T (1990) Cytoskeletal components of the adherens junctions between the photoreceptors and the supportive M\u00fcller cells. J Comp Neurol 295(1):155\u2013164","journal-title":"J Comp Neurol"},{"issue":"2","key":"10016_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1006\/excr.1999.4534","volume":"250","author":"R Paffenholz","year":"1999","unstructured":"Paffenholz R et al (1999) The arm-repeat protein NPRAP (neurojungin) is a constituent of the plaques of the outer limiting zone in the retina, defining a novel type of adhering junction. Exp Cell Res 250(2):452\u2013464","journal-title":"Exp Cell Res"},{"key":"10016_CR29","unstructured":"Noor M et al Retinopathy in Mucopolysaccharidoses. Ophthalmology."},{"issue":"10","key":"10016_CR30","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1167\/iovs.14-15126","volume":"55","author":"W Lee","year":"2014","unstructured":"Lee W et al (2014) The external limiting membrane in early-onset Stargardt disease. Invest Ophthalmol Vis Sci 55(10):6139\u20136149","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10016_CR31","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/genes11121421","volume":"11","author":"YC Sung","year":"2020","unstructured":"Sung YC et al (2020) Genotypes predispose phenotypes-clinical features and genetic spectrum of ABCA4-associated retinal dystrophies. Genes (Basel) 11(12):1421","journal-title":"Genes (Basel)"},{"issue":"5","key":"10016_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/sj.eye.6701921","volume":"20","author":"JL Ashworth","year":"2006","unstructured":"Ashworth JL et al (2006) The ocular features of the mucopolysaccharidoses. Eye 20(5):553\u2013563","journal-title":"Eye"},{"issue":"6","key":"10016_CR33","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1073\/pnas.87.6.2117","volume":"87","author":"R Wen","year":"1990","unstructured":"Wen R, Oakley B 2nd (1990) K(+)-evoked M\u00fcller cell depolarization generates b-wave of electroretinogram in toad retina. Proc Natl Acad Sci U S A 87(6):2117\u20132121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10016_CR34","doi-asserted-by":"publisher","first-page":"E010","DOI":"10.1017\/S0952523821000092","volume":"38","author":"AV Dmitriev","year":"2021","unstructured":"Dmitriev AV, Dmitriev AA, Linsenmeier RA (2021) K(+)-dependent M\u00fcller cell-generated components of the electroretinogram. Vis Neurosci 38:E010","journal-title":"Vis Neurosci"},{"issue":"2","key":"10016_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ki.2015.317","volume":"89","author":"DA Braun","year":"2016","unstructured":"Braun DA et al (2016) Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity. Kidney Int 89(2):468\u2013475","journal-title":"Kidney Int"},{"issue":"7676","key":"10016_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature.2017.22819","volume":"550","author":"H Ledford","year":"2017","unstructured":"Ledford H (2017) FDA advisers back gene therapy for rare form of blindness. Nature 550(7676):314","journal-title":"Nature"},{"issue":"1","key":"10016_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","volume":"130","author":"SG Jacobson","year":"2012","unstructured":"Jacobson SG et al (2012) Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 130(1):9\u201324","journal-title":"Arch Ophthalmol"},{"issue":"10097","key":"10016_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S et al (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390(10097):849\u2013860","journal-title":"Lancet"},{"issue":"2","key":"10016_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jop.2018.0087","volume":"35","author":"Gene Therapy for Inherited Retinal Degeneration","year":"2019","unstructured":"Gene Therapy for Inherited Retinal Degeneration (2019) J Ocul Pharmacol Ther 35(2):79\u201397","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10016_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/IAE.0000000000003133","volume":"41","author":"BP Leroy","year":"2021","unstructured":"Leroy BP et al (2021) Leber congenital amaurosis due to cep290 mutations-severe vision impairment with a high unmet medical need: a review. Retina 41(5):898\u2013907","journal-title":"Retina"},{"issue":"5","key":"10016_CR41","first-page":"102409","volume":"24","author":"SG Jacobson","year":"2021","unstructured":"Jacobson SG et al (2021) Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations. Science 24(5):102409","journal-title":"Science"},{"issue":"7785","key":"10016_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV et al (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576(7785):149\u2013157","journal-title":"Nature"},{"issue":"22","key":"10016_CR43","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen PJ et al (2021) Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184(22):5635-5652.e29","journal-title":"Cell"},{"issue":"8","key":"10016_CR44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00439-013-1297-0","volume":"132","author":"J Halbritter","year":"2013","unstructured":"Halbritter J et al (2013) Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum Genet 132(8):865\u2013884","journal-title":"Hum Genet"},{"issue":"12","key":"10016_CR45","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jamaophthalmol.2017.4859","volume":"135","author":"JH Rim","year":"2017","unstructured":"Rim JH et al (2017) Accuracy of next-generation sequencing for molecular diagnosis in patients with infantile nystagmus syndrome. JAMA Ophthalmol 135(12):1376\u20131385","journal-title":"JAMA Ophthalmol"},{"key":"10016_CR46","doi-asserted-by":"publisher","first-page":"32792","DOI":"10.1038\/srep32792","volume":"6","author":"Q Zhang","year":"2016","unstructured":"Zhang Q et al (2016) Next-generation sequencing-based molecular diagnosis of 35 Hispanic retinitis pigmentosa probands. Sci Rep 6:32792","journal-title":"Sci Rep"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-025-10016-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T03:44:16Z","timestamp":1749095056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-025-10016-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10016"],"URL":"https:\/\/doi.org\/10.1007\/s10633-025-10016-3","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.H.T receives financial support from Abeona Therapeutics, Inc and Emendo and is on the scientific and clinical advisory board for Nanoscope Therapeutics. Peter M.J. Quinn is supported by the Curing Retinal Blindness Foundation (CRBF), a Foundation Fighting Blindness Individual Investigator Research Award, and the NIH R01EY034952. J.P., B.L.D, M.R., A.Z, M.D.K., and J.R.S. have no conflicting interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted under the Columbia University Institutional Review Board-approved protocol IRB AAAR8743, and all procedures were performed in accordance with the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived due to the retrospective nature of the study and the minimal risk conferred to patients as per the Columbia University Institutional Review Board-approved protocol AAAR8743.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted under the Columbia University Institutional Review Board-approved protocol IRB AAAR8743, and all procedures were performed in accordance with the tenets of the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"No animals were used in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}